11/20
10:59 am
asmb
Assembly Biosciences (NASDAQ:ASMB) was given a new $40.00 price target on by analysts at Mizuho.
Medium
Report
Assembly Biosciences (NASDAQ:ASMB) was given a new $40.00 price target on by analysts at Mizuho.
11/10
04:58 pm
asmb
Assembly Biosciences GAAP EPS of -$0.72 beats by $0.06, revenue of $10.79M beats by $1.47M [Seeking Alpha]
Medium
Report
Assembly Biosciences GAAP EPS of -$0.72 beats by $0.06, revenue of $10.79M beats by $1.47M [Seeking Alpha]
11/10
04:19 pm
asmb
Assembly Biosciences Reports Third Quarter 2025 Financial Results and Recent Updates [Yahoo! Finance]
Medium
Report
Assembly Biosciences Reports Third Quarter 2025 Financial Results and Recent Updates [Yahoo! Finance]
11/10
04:05 pm
asmb
Assembly Biosciences Reports Third Quarter 2025 Financial Results and Recent Updates
Medium
Report
Assembly Biosciences Reports Third Quarter 2025 Financial Results and Recent Updates
11/7
08:00 am
asmb
Assembly Biosciences Presents Positive Phase 1b Data for Next-Generation Capsid Assembly Modulator ABI-4334 at AASLD The Liver Meeting®
Low
Report
Assembly Biosciences Presents Positive Phase 1b Data for Next-Generation Capsid Assembly Modulator ABI-4334 at AASLD The Liver Meeting®
10/24
12:16 pm
asmb
Assembly Biosciences (NASDAQ:ASMB) had its "sell (d-)" rating reaffirmed by analysts at
Weiss Ratings.
Low
Report
Assembly Biosciences (NASDAQ:ASMB) had its "sell (d-)" rating reaffirmed by analysts at
Weiss Ratings.
10/14
08:08 am
asmb
Assembly Biosciences (NASDAQ:ASMB) had its "buy" rating reaffirmed by analysts at HC Wainwright. They now have a $50.00 price target on the stock.
Medium
Report
Assembly Biosciences (NASDAQ:ASMB) had its "buy" rating reaffirmed by analysts at HC Wainwright. They now have a $50.00 price target on the stock.
10/14
07:53 am
asmb
Assembly Biosciences Announces Upcoming Investor Conference Participation [Yahoo! Finance]
Low
Report
Assembly Biosciences Announces Upcoming Investor Conference Participation [Yahoo! Finance]
10/14
07:00 am
asmb
Assembly Biosciences Announces Upcoming Investor Conference Participation
Medium
Report
Assembly Biosciences Announces Upcoming Investor Conference Participation
10/10
08:00 am
asmb
Assembly Biosciences Presents Interim Phase 1b Data for HSV Helicase-Primase Inhibitor Candidate ABI-5366 at the 38th Congress of the International Union Against Sexually Transmitted Infections (IUSTI)- Europe
Low
Report
Assembly Biosciences Presents Interim Phase 1b Data for HSV Helicase-Primase Inhibitor Candidate ABI-5366 at the 38th Congress of the International Union Against Sexually Transmitted Infections (IUSTI)- Europe
10/3
03:30 pm
asmb
Assembly Biosciences (NASDAQ:ASMB) had its "sell (d-)" rating reaffirmed by analysts at
Weiss Ratings.
Low
Report
Assembly Biosciences (NASDAQ:ASMB) had its "sell (d-)" rating reaffirmed by analysts at
Weiss Ratings.
9/24
10:12 am
asmb
Assembly Biosciences (NASDAQ:ASMB) is now covered by analysts at Citigroup Inc.. They set an "outperform" rating on the stock.
Medium
Report
Assembly Biosciences (NASDAQ:ASMB) is now covered by analysts at Citigroup Inc.. They set an "outperform" rating on the stock.
9/24
09:06 am
asmb
Assembly Biosciences (NASDAQ:ASMB) is now covered by analysts at JMP Securities. They set a "market outperform" rating and a $38.00 price target on the stock.
Medium
Report
Assembly Biosciences (NASDAQ:ASMB) is now covered by analysts at JMP Securities. They set a "market outperform" rating and a $38.00 price target on the stock.
9/24
08:09 am
asmb
Assembly Biosciences (NASDAQ:ASMB) is now covered by analysts at Citizens Jmp. They set an "outperform" rating and a $38.00 price target on the stock.
Medium
Report
Assembly Biosciences (NASDAQ:ASMB) is now covered by analysts at Citizens Jmp. They set an "outperform" rating and a $38.00 price target on the stock.
9/22
07:03 am
asmb
Assembly Biosciences Up 15%, Insider Buyers Are Up 65% [Yahoo! Finance]
Low
Report
Assembly Biosciences Up 15%, Insider Buyers Are Up 65% [Yahoo! Finance]
9/8
09:58 am
asmb
Assembly Biosciences (NASDAQ:ASMB) had its price target raised by analysts at Guggenheim from $31.00 to $39.00. They now have a "buy" rating on the stock.
Low
Report
Assembly Biosciences (NASDAQ:ASMB) had its price target raised by analysts at Guggenheim from $31.00 to $39.00. They now have a "buy" rating on the stock.